YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Bayer, Loxo to collaborate on cancer drugs

Posted online

Loxo Oncology Inc. and Bayer are collaborating to develop and commercialize two cancer drugs.

The deal could bring the U.S. drug developer up to $1.55 billion.

Loxo will receive a $400 million upfront payment, followed by incentive payments for milestones.

Read more from RTT News.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences